INTRODUCTION
============

Risk stratification has always been considered crucial in patients with non-small cell lung cancer (NSCLC) undergoing lung resection. The decline in the respiratory function after surgery remains a noteworthy drawback despite the advances in surgical techniques and perioperative care. The current guidelines of the European Respiratory Society and the European Society of Thoracic Surgery[@B1] strongly suggest the assessment of patients' physical performance by a functional-based algorithm. Peak oxygen uptake (VO~2peak~) has shown to be the best independent predictor of surgical complication rates[@B2] ^-^ [@B7] and, for this reason, cardiopulmonary exercise testing (CPET) is recommended when preoperative FEV~1~ and/or DLCO are \< 80% of the predicted values.[@B1] Therefore, preoperative evaluation of respiratory function is one of the most important factors to determine operability, especially in patients with COPD.[@B1] ^-^ [@B3] ^,^ [@B8] Although VO~2peak~ is certainly the most widely used variable, CPET provides various other direct and indirect indicators that change in response to incremental workloads. Consistent data are emerging about the relationship between minute ventilation (V~E~) and carbon dioxide output (VCO~2~), also called the ventilatory efficiency slope. Patients with lung disease have increased ventilatory requirements for a given level of exercise.[@B9] In two independent studies that involved patients undergoing lung resections, a higher V~E~/VCO~2~ slope showed to be a predictor of surgical complications and increased mortality.[@B3] ^,^ [@B8] A few studies reported the impact of preoperative pulmonary rehabilitation programs (PRPs) on exertional parameters in cohorts of NSCLC patients undergoing radical surgery.[@B10] ^-^ [@B12] Therefore, the aim of the present study was to evaluate the effects of a preoperative high-intensity PRP on the V~E~/VCO~2~ slope in a cohort of patients with COPD undergoing lung resection for NSCLC.

METHODS
=======

Patients
--------

We retrospectively evaluated the electronic medical records of 32 consecutive COPD patients attending a preoperative high-intensity PRP prior to undergoing lung surgery for NSCLC, between December of 2015 and January of 2017. Inclusion criteria were having been previously diagnosed with clinical stage I-IIIa NSCLC; being deemed fit for surgery according to the European Respiratory Society/European Society of Thoracic Surgery guidelines[@B1]; being \< 80 years of age; having a body mass index of 18-34 kg/m^2^; and presenting with a postbronchodilator fixed FEV~1~/FVC ratio \< 0.70. Exclusion criteria were contraindications to surgery based on baseline CPET; cardiovascular or musculoskeletal disorders limiting training; use of oxygen therapy or noninvasive ventilation for chronic lung failure; cognitive impairment or psychiatric disorders; and pregnancy. The PRP was offered to patients with COPD who had a VO~2peak~ ≤ 15.0 mL/kg per min or an FEV~1~ ≤ 50% of the predicted value and were awaiting surgical resection. The inclusion of patients in the PRP was not a reason for postponing surgical resection in any case. Patients who were deemed fit for surgery underwent open thoracotomy or video-assisted lobectomy three weeks after the beginning of PRP. COPD treatment was not modified during the observation period. Complete functional assessment, including spirometry, DLCO measurement, and CPET, was carried out, in accordance with our routine practice, before and after the PRP, both prior to surgery.

CPET and evaluation of dyspnea
------------------------------

Before and after the PRP, CPET was performed using a ramp protocol and breath-by-breath measurements on a cycle ergometer (Ergoline Ergoselect; SensorMedics, Milan, Italy) connected to computerized analyzer (Vmax encore 29C; SensorMedics). Hemodynamic and respiratory parameters were monitored during the test, including blood pressure, SpO~2~, heart rate (HR), electrocardiogram, exhaled O~2~, and exhaled CO~2~. The test started with a 2-min evaluation of the patient at rest, followed by a 2-min warm-up period during which the patient cycled freely. Exercise intensity was gradually increased based on the predicted workload for each patient. The test was interrupted when the patient reached the maximum predicted HR or whether other limitations occurred. At the end of the CPET, the reasons for exercise limitation and the perception of dyspnea, determined by the Borg scale, were registered.

PRP
---

A PRP, in daily 3-h sessions from Monday to Friday, was carried out for 3 consecutive weeks.[@B10] In brief, the program consisted of respiratory exercises on a bench, on a mattress pad, and using wall bars. Subsequently, high-intensity training for the upper limbs (on a rowing ergometer) and the lower limbs (on a treadmill or cycle ergometer) were carried out. For rowing and walking, training was conducted at a perceived exertion rating of 15-17 (hard to very hard) on the Borg Rating of Perceived Exertion scale.[@B13] For cycling, the exercise workload was set according to CPET results for each patient, starting with 70% of the maximum score reached in CPET and increased by 10 W when the patient was able to tolerate that workload for 30 min.[@B10] ^,^ [@B11] High-intensity exercises lasted for 10-15 min. In the presence of physical exhaustion or severe dyspnea, the exercise was prematurely interrupted. The training sessions were supervised by an experienced physical therapist.

Statistical analysis
--------------------

Data are reported as frequencies, means, and standard deviations; for respiratory parameters, absolute and percentage of the predicted values were considered. Intragroup analysis was performed using a t-test for dependent variables. The level of significance was set at 5%.

RESULTS
=======

Of the 32 patients evaluated, 7 were excluded because of incomplete PRP or lack of post-PRP assessment: 5 patients (15.6%) underwent surgery at other hospitals; and 2 (6.2%) abandoned the PRP after less than one week. Therefore, the sample comprised 25 patients (17 males and 8 females) diagnosed with resectable NSCLC (stage I-IIIa). The mean age was 62.3 ± 6.0 years. The baseline characteristics of the patients are summarized in [Table 1](#t1){ref-type="table"}, whereas [Table 2](#t2){ref-type="table"} shows the comparison of characteristics between included and excluded patients. All of the patients had a baseline VO~2peak~ ranging from 10 to 20 mL/kg per min (mean, 14.7 ± 2.5 mL/kg per min). Three patients (12%) had a previous diagnosis of chronic heart failure, and 16 (64%) had systemic hypertension. [Table 3](#t3){ref-type="table"} compares spirometry and CPET parameters before and after the 3-week PRP. As expected, the major spirometry variables showed no significant differences between the pre- and post-PRP values. Conversely, the VO~2peak~ improved significantly after the PRP (14.7 ± 2.5 mL/kg per min vs. 18.2 ± 2.7 mL/kg per min; p \< 0.001), as did the V~E~/VCO~2~ slope (32.0 ± 2.8 vs. 30.1 ± 4.0; p \< 0.01).

Table 1Baseline characteristics of the patients (N = 25).^a^CharacteristicResultAge, years62.3 ± 6.0Gender, male17 (68)Smoking history, pack-years37.2 ± 8.0BMI, kg/m^2^26.1 ± 3.4FEV~1~, L1.67 ± 0.7FEV~1~, % predicted61.5 ± 22.0FEV~1~/FVC54.1 ± 13.1TLC, % predicted108.7 ± 28.6IC, % predicted84.4 ± 14.3IC/TLC38.5 ± 12.1RV, % predicted130.0 ± 39.4DLCO, % predicted67.2 ± 18.1VO~2peak~, mL/kg per min14.7 ± 2.5VO~2peak~, % predicted64.1 ± 19.2COPD stagingI4 (16)II9 (36)III/IV12 (48)COPD treatmentLAMA3 (12)LABA1 (4)LABA/LAMA16 (64)LABA/LAMA/ICS5 (20)TNM stagingIa6 (24)Ib8 (32)IIa7 (28)IIb4 (16)[^1]

Table 2Spirometry and cardiopulmonary exercise test parameters before and after the three-week pulmonary rehabilitation program.ParameterBeforeAfterpFEV~1~, % predicted61.5 ± 22.061,9 ± 21.1nsVC, % predicted81.1 ± 19.082.0 ± 17.8nsFEV~1~/VC54.1 ± 13.154.5 ± 14.1nsDLCO, % predicted67.2 ± 18.167.5 ± 13.2nsVO~2peak~, mL/kg per min14.7 ± 2.518.2 ± 2.7\< 0,001VO~2peak~, % predicted64.0 ± 19.281.1 ± 18.0\< 0,001V~E~/VCO~2~ slope32.0 ± 2.830.1 ± 4.0\< 0,01Peak HR, % predicted92.1 ± 1.892.3 ± 2.0nsPeak RER1.2 ± 0.31.3 ± 0.2nsBreathing reserve, %24.3 ± 6.124.7 ± 6.4ns[^2]

Table 3Baseline characteristics of included and excluded patients.^a^CharacteristicIncluded patientsExcluded patientspAge, years62.3 ± 6.060.4 ± 5.10.45GenderMale17 (68.0)5 (71.4)0.94Female8 (32.0)2 (28.6)0.90Smoking history, pack-years37.2 ± 8.032.2 ± 9.10.16BMI, kg/m^2^26.1 ± 3.427.5 ± 2.90.33FEV~1~, L1.67 ± 0.701.84 ± 0.600.56FEV~1~, % predicted61.5 ± 22.063.4 ± 26.20.84FEV~1~/FVC54.1 ± 13.159.1 ± 10.10.36TLC, % predicted108.7 ± 28.6111.1 ± 27.20.83IC, % predicted84.4 ± 14.387.1 ± 12.90.64IC/TLC38.5 ± 12.135.4 ± 15.90.64RV, % predicted130.0 ± 39.4124.5 ± 42.10.76DLCO, % predicted67.2 ± 18.171.0 ± 16.50.60VO~2peak~, mL/kg per min14.7 ± 2.515.1 ± 2.80.73VO~2peak~, % predicted64.1 ± 19.267.8 ± 21.10.68COPD stagingI/II13 (52.0)3 (42.8)0.80III/IV12 (48.0)4 (57.2)0.81TNM stagingIa-b14 (56.0)4 (57.1)0.98IIa-b11 (44.0)3 (42.9)0.97[^3]

DISCUSSION
==========

In the present study, we found that a high-intensity PRP in patients with COPD undergoing lung resection for NSCLC might influence exertional parameters by increasing VO~2peak~ and reducing the V~E~/VCO~2~ slope. The risk of lung cancer is approximately five times greater in patients with COPD than in smokers without COPD, regardless of age and smoking history.[@B14] ^-^ [@B18] In patients in the early stages of NSCLC,[@B19] the presence of coexisting COPD has been correlated with shorter survival, although no convincing evidence of such a correlation has been found in patients with nonresectable tumors.[@B20] In our study population, most of the subjects were heavy smokers with poor pulmonary function test results, which did not improve significantly after the high-intensity PRP. These data are consistent with those of similar studies in the literature[@B21] ^,^ [@B22] and could have been due to the short duration of the PRP. Nevertheless, exertional parameters improved meaningfully, indicating the positive effects of such a program on overall fitness and efficiency of CO~2~ elimination. A previous prospective study[@B10] showed that VO~2peak~ could be influenced by a PRP. To our knowledge, there are as yet no data about the V~E~/VCO~2~ slope in relation to a PRP. The V~E~/VCO~2~ slope reflects a combination of factors that underlie ventilatory inefficiency and can be altered by both pulmonary and cardiac diseases. However, Corrà et al.[@B23] reported that a V~E~/VCO~2~ \> 35 is a predictor of mortality, independently from VO~2max~, in a cohort of patients with chronic heart failure. Those results were subsequently corroborated in three large studies that involved patients undergoing lung resection for NSCLC.[@B3] ^,^ [@B5] ^,^ [@B8] A comprehensive retrospective analysis investigated 145 consecutive patients with COPD referred for preoperative evaluation.[@B8] The authors concluded that a high V~E~/VCO~2~ slope can be considered an independent predictor of postoperative mortality among patients with COPD undergoing lung resection, no deaths having occurred in patients with a V~E~/VCO~2~ slope within the normal range.[@B8] Brunelli et al.[@B3] found that the V~E~/VCO~2~ slope was the only significant factor associated with the risk of complications, showing that the incidence of complications and mortality were 3- and 12-fold higher, respectively, among patients with a V~E~/VCO~2~ slope \> 35 than among those with lower values. More recently, a V~E~/VCO~2~ slope \> 35 (at maximal exercise) was strongly associated with the probability of mortality and postoperative complications, as well as with a 1-year survival rate of 40%.[@B5] However, the latter study had one major weakness: the authors did not clearly state whether mortality was related to cancer or not. The clinical meaning of those findings remains to be determined, not only in the context of postoperative pulmonary complications/mortality after lung resection due to lung cancer but also in the context of the clinical implications of excessive ventilation during exercise on exertional dyspnea in COPD. In fact, a decrease in the V~E~/VCO~2~ slope after a PRP could be influenced by increased CO~2~ elimination and by reduced exercise ventilation after training.[@B24] Porszasz et al.[@B25] investigated the magnitude of improvement in exercise tolerance and dynamic hyperinflation in a population of severe COPD patients undergoing a 7-week high-intensity PRP. After the PRP, the patients showed decreased dynamic hyperinflation and breathing frequency during a constant work rate test on a cycle ergometer. In addition, the multivariate analysis revealed that the improvement in inspiratory capacity was significantly associated with the changes in exercise tolerance. However, the role of PRPs in the setting of NSCLC surgery has yet to be clarified. Mainini et al.,[@B26] in an elegant systematic review, emphasized that PRPs should be better studied due to the scarcity of randomized clinical trials regarding preoperative and postoperative PRPs, the few such studies having produced inconsistent results. The effects of pulmonary rehabilitation in COPD patients undergoing NSCLC surgery are currently under investigation in two clinical trials ([NCT00363428](NCT00363428) and [NCT02887521](NCT02887521)). The effects of a longer PRP, including preoperative and postoperative training, are also under investigation ([NCT02405273](NCT02405273)).

Despite the small number of patients, our study offers novel insights in this field of research. However, the present study has some limitations. First, because of the retrospective design of the study, we were unable to report the 1-year survival rate of the patients studied, which would be an interesting long-term outcome measure of the value of a PRP. In addition, the number of patients who were unable to complete the PRP and were therefore excluded from the final analysis represents a potential limitation of the study. However, no differences were found between the two groups at baseline.

In conclusion, our results underscore the influence of a high-intensity PRP on ventilation efficiency. Further comprehensive prospective studies are required in order to corroborate these preliminary results.
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[^1]: BMI: body mass index; IC: inspiratory capacity; VO~2peak~: peak oxygen uptake; LABA: long-acting β~2~ agonists; LAMA: long-acting muscarinic antagonists, ICS: inhaled corticosteroids; and TNM: tumor-lymph node-metastasis. ^a^Values expressed as n (%) or mean ± SD.

[^2]: ns: not significant; VO~2peak~: peak oxygen uptake; V~E~: minute ventilation; VCO~2~: carbon dioxide output; and RER: respiratory exchange ratio.

[^3]: BMI: body mass index; IC: inspiratory capacity; VO~2peak~: peak oxygen uptake; and TNM: tumor-lymph node-metastasis. ^a^Values expressed as n (%) or mean ± SD.
